Vapotherm (NYSE:VAPO) is Profiled in this Database

Updated At 05 Apr, 2014

Partial description of this company

Next-generation respiratory device that delivers synchronization of flow/temperature/humidity/oxygen percentage, without discomfort, via nasal cannula, for patients with chronic or acute breathing disorders

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Vapotherm (NYSE:VAPO) plus 4970 other startups.

Start Free 7 Day Trial Now

Learn More About Vapotherm (NYSE:VAPO)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy